Irritable Bowel Syndrome Trial, Recruiting (NCT07283341)

Irritable Bowel Syndrome Trial, Recruiting NCT07283341 Sponsor: Children's Hospital of Philadelphia Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT07283341 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If joining as a "Case" (child with IBS):

The child is between 8 and 18 years old (male or female)
The child has been diagnosed with irritable bowel syndrome (IBS)
A parent or guardian agrees to take part, and the child also agrees to take part

If joining as a "Control" (child without a bowel pain condition):

The child is between 8 and 18 years old (male or female)
The child has NOT been diagnosed with any abdominal (stomach) pain disorder
A parent or guardian agrees to take part, and the child also agrees to take part

Who may not be able to join:

(This applies to both groups)

The child has an allergy to adhesives (sticky materials, like those used in bandages or stickers)
The child would not be able to follow along with how the study is set up (confirm with trial site)
The child has taken antibiotics in the last 4 weeks
The child has been diagnosed with an inflammatory gastrointestinal disorder (a condition causing inflammation in the gut, such as Crohn's disease or ulcerative colitis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alain Benitez, MD, MSTR, Children's Hospital of Philadelphia, University of Pennsylvania

Phone: 215-590-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07283341

Sponsor: Children's Hospital of Philadelphia

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: 215-590-1000

More information: https://clinicaltrials.gov/study/NCT07283341

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

If joining as a "Case" (child with IBS):

The child is between 8 and 18 years old (male or female)
The child has been diagnosed with irritable bowel syndrome (IBS)
A parent or guardian agrees to take part, and the child also agrees to take part

If joining as a "Control" (child without a bowel pain condition):

The child is between 8 and 18 years old (male or female)
The child has NOT been diagnosed with any abdominal (stomach) pain disorder
A parent or guardian agrees to take part, and the child also agrees to take part

Who may not be able to join:

(This applies to both groups)

The child has an allergy to adhesives (sticky materials, like those used in bandages or stickers)
The child would not be able to follow along with how the study is set up (confirm with trial site)
The child has taken antibiotics in the last 4 weeks
The child has been diagnosed with an inflammatory gastrointestinal disorder (a condition causing inflammation in the gut, such as Crohn's disease or ulcerative colitis)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Children's Hospital of Philadelphia

Registry

ClinicalTrials.gov

Start date

31 July 2023

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Gut myoelectric activity in children with IBS and controls using the non-invasive wireless patch system (WPS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov